Drug intelligence / Profile preview

amphiregulin

Development stage
Preclinical
Lead developer
Mỹ Đức Hospital
Modality
Hormones & Growth Factors → Recombinant Proteins and Enzymes
Administration
Parenteral
01

Overview

**Amphiregulin** is an endogenous epidermal growth factor family ligand and heparin-binding protein that activates **epidermal growth factor receptor** signaling, driving cellular proliferation, differentiation, tissue repair, and fibroblast activation. In the provided public sources, amphiregulin appears both as a biologic culture supplement used in assisted reproduction and as a disease-relevant signaling molecule in fibrosis and inflammatory disorders. A registered interventional fertility study at My Duc Hospital lists amphiregulin as a drug intervention in in vitro maturation media for oocytes, indicating human interventional use in an ART setting, while peer-reviewed and meeting literature describe amphiregulin as a mediator of intestinal, pulmonary, skin, and other fibrotic or inflammatory processes. It is not an approved branded medicine and is better understood as a recombinant or exogenous form of a native human growth factor used experimentally and translationally rather than as a conventional commercial therapeutic drug.

Other names
amphiregulinAREGAR
02

Targets

EGFR T790M (Epidermal growth factor receptor T790M mutant)

Beyond the preview

Go deeper on amphiregulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on amphiregulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call